Incyte Corp at Piper Jaffray Healthcare Conference Transcript
Good morning, everyone. Thanks very much for being here and welcome to the second day of the 31st Annual Piper Jaffray Healthcare Conference. With us for this session, we're very pleased to have Incyte in attendance. And from Incyte, we have Hervé Hoppenot, the Chairman and President and CEO; and Christiana Stamoulis, the Executive Vice President and CFO.
Questions & Answers
So Hervé, as evidenced by the current stock price, you guys have had a pretty good year. And in addition to continuing to execute on the Jakafi Jakavi launch, and executing on the pipeline and the post IDO era, I thought it would be helpful just to start by discussing your confidence in the existing Jakavi Jakafi franchise and the breadth of the pipeline and the overall state of the business.
© -
Okay. Thank you. Thank you for having us here. So when you look at the portfolio of Incyte today, so you have the existing Jakafi franchise
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |